If you have been searching for OCD treatment providers, you have probably noticed how varied the options are. Some practices offer OCD medication and refer out for therapy. Others offer exposure and response prevention (ERP) therapy but do not prescribe. A small number offer both. Effective OCD treatment patients can rely on usually requires understanding which combination is right for your situation, what the right OCD medication psychiatrists typically prescribe, and how the medication-plus-therapy pairing actually works.
This article walks through what OCD treatment looks like in 2026: the medications that have the strongest evidence, what to expect from an OCD evaluation, how to find a psychiatrist who specializes in OCD, the role of ERP therapy alongside OCD medication that patients are typically prescribed, and the practical considerations around cost, insurance, and telehealth versus in-person care.
What effective OCD treatment actually looks like
OCD treatment providers fall into two main evidence-supported categories: medication and a specific type of psychotherapy called Exposure and Response Prevention (ERP). The strongest outcomes come from combined treatment using both. Research consistently shows that the combination of OCD medication psychiatrists typically prescribe (first-line, this means an SSRI) plus ERP therapy produces faster and more durable improvement than either alone for moderate to severe OCD.
The clinical reality in NYC is that most psychiatric practices and most ERP-trained therapy practices are separate. A psychiatrist providing OCD medication patients trust typically refers to ERP therapists for the psychotherapy component, while ERP therapists refer to psychiatrists for medication. A small number of practices offer both under one roof. For most patients, building the right OCD treatment plan means finding both a psychiatric prescriber and an ERP-trained therapist, then coordinating between them.
OCD is one of the more treatable serious psychiatric conditions when the right combination of treatments is applied. The hardest part is usually finding providers with genuine OCD expertise rather than general anxiety treatment, because OCD has specific medication dosing requirements and a specific therapy approach that differ meaningfully from generic anxiety care.
SSRIs: the first-line OCD medication in psychiatric practice
Selective serotonin reuptake inhibitors are the first-line OCD medication psychiatrists prescribe across nearly all OCD presentations. Four SSRIs hold FDA approval specifically for OCD: fluoxetine (Prozac), sertraline (Zoloft), paroxetine (Paxil), and fluvoxamine (Luvox). Citalopram (Celexa) and escitalopram (Lexapro) are commonly used off-label with similar efficacy in clinical practice.
Two clinical points distinguish OCD medication patients receive from antidepressant prescribing for depression or anxiety. First, the doses are typically higher. Fluoxetine for depression is often dosed at 20 mg per day; for OCD, doses of 40 to 80 mg per day are common. Sertraline for depression is typically 50 to 100 mg per day; for OCD, 150 to 200 mg per day is more typical. These higher doses are well-established in OCD treatment guidelines and reflect the way the condition responds to serotonergic agents.
Second, the trial periods are longer. Standard antidepressant practice is to judge response at four to six weeks. For OCD medication, the standard is to wait ten to twelve weeks at an adequate dose before deciding whether the SSRI is working. Many patients labeled as “treatment-resistant OCD” in have actually had inadequate trials, meaning doses never titrated high enough or trials stopped at six weeks when twelve weeks at the higher dose would have produced response. A psychiatrist familiar with OCD-specific dosing and trial duration is an important part of effective OCD treatment patients should look for.
Common SSRI side effects in the context of OCD treatment include nausea (first few weeks), changes in sleep, sexual side effects, and emotional blunting in some patients. Starting low and titrating gradually toward the OCD-effective dose range is standard practice. Some patients tolerate one SSRI better than another, which is why a sequence of SSRI trials is sometimes needed before finding the right fit.
When SSRIs aren’t enough: clomipramine, antipsychotic augmentation, and TMS
For OCD that has not responded adequately to SSRIs at OCD-appropriate doses for OCD-appropriate trial duration, several next-line OCD medication psychiatrists may consider exist.
Clomipramine (Anafranil) is a tricyclic antidepressant with strong evidence specifically for OCD. It works on serotonin reuptake but has additional effects on other neurotransmitter systems. Clomipramine produces response rates comparable to or higher than SSRIs in some studies, but it carries a heavier side effect burden, including dry mouth, constipation, weight gain, dizziness, and ECG changes (which require monitoring). For OCD treatment patients with severe OCD who have not responded to two SSRIs, clomipramine is a reasonable next-line option. It is sometimes used in combination with an SSRI under careful management.
Antipsychotic augmentation is the most evidence-supported next step for treatment-resistant OCD. Atypical antipsychotics including risperidone (Risperdal), aripiprazole (Abilify), and quetiapine (Seroquel) are added to an existing SSRI rather than replacing it. The augmentation strategy has the strongest evidence in OCD treatment among the next-line options. Doses are typically lower than those used for psychotic disorders. Side effects (weight gain, metabolic changes, occasional movement-related effects) require monitoring. For someone whose OCD has not responded fully to SSRI alone, augmentation with low-dose risperidone or aripiprazole is the standard next step in psychiatric practice.
Transcranial magnetic stimulation (TMS) received FDA approval for OCD in 2018, using a specific protocol called Deep TMS with an H7 coil that targets the dorsomedial prefrontal cortex and anterior cingulate cortex. TMS is non-invasive, requires no anesthesia, and is well-tolerated. The course typically involves daily sessions over four to six weeks. TMS for OCD is increasingly available at academic and private psychiatric practices. It is an option for patients who have not responded adequately to medication alone or who prefer non-medication intervention.
Intensive outpatient programs (IOPs) and residential treatment are options for severe OCD that has not responded to standard outpatient care. and the surrounding region have several specialized OCD treatment programs offering intensive ERP, medication management, and structured treatment over several weeks.
Deep brain stimulation (DBS) is FDA-approved for severe treatment-resistant OCD but is reserved for the most severe cases that have not responded to multiple medication trials, ERP, TMS, and other interventions. It involves implantation of electrodes and is performed at a small number of specialized academic centers.
Why ERP therapy is essential alongside OCD medication patients should know about
Medication alone is rarely sufficient for moderate to severe OCD. Exposure and Response Prevention (ERP) is the gold-standard psychotherapy for OCD and produces durable improvements that medication alone does not always sustain. Combining OCD medication patients receive with ERP therapy produces the strongest outcomes in nearly every published study comparing single-modality versus combination treatment.
ERP works by gradually exposing the patient to the triggers that provoke obsessions (contamination, harm thoughts, symmetry, taboo content, or other OCD subtypes) while preventing the compulsions that would normally follow. Over repeated exposures, the brain learns that the feared outcome does not occur and that anxiety subsides on its own without performing the ritual. This process, called habituation, is the central mechanism by which ERP produces lasting change.
ERP is structured and specific. A skilled ERP therapist builds an exposure hierarchy with the patient (a list of triggers ranked by anxiety level), then works through them systematically with response prevention. Generic talk therapy and cognitive behavioral therapy without the specific exposure component are less effective for OCD than ERP. This is one of the reasons finding ERP-trained therapists matters more than finding generic anxiety therapists when seeking OCD treatment patients can rely on.
Most psychiatric practices offering OCD medication patients work with do not provide ERP therapy directly. The standard model is medication management by a psychiatric prescriber, ERP therapy by a separately credentialed therapist, and coordination between the two providers. My practice provides medication management for OCD and works alongside ERP-trained therapists in the and NJ area for the therapy component. The combination produces the strongest outcomes for OCD, and I refer to specific ERP therapists who have demonstrated expertise with the condition.
Finding the right OCD specialist in
Several practical questions help identify whether a prospective OCD treatment provider is the right fit.
Does the psychiatrist specialize in OCD or treat it occasionally? Generalist psychiatrists treat OCD competently, but practices with deeper OCD expertise are more likely to handle the diagnostic nuances, comfortable with OCD-specific dosing of SSRIs and longer trial periods, and aware of clomipramine and augmentation strategies when first-line treatment is not enough.
Is the prescriber comfortable with higher OCD-dosing of SSRIs? A psychiatrist who hesitates to titrate fluoxetine above 40 mg or sertraline above 100 mg may be providing depression-style dosing rather than OCD-effective dosing. Asking directly about the typical dose range used for OCD is a useful question.
Does the practice refer to ERP-trained therapists? A psychiatrist who recognizes the importance of ERP and has working relationships with ERP-trained therapists in the area provides better integrated care than one who only prescribes.
What is the experience with treatment-resistant OCD? If your OCD has not responded to one or two SSRI trials already, you want a psychiatrist familiar with clomipramine, augmentation strategies, TMS referrals, and intensive treatment options. This experience is not universal.
What is the practice’s approach to OCD subtypes? OCD presents in many forms, including contamination, harm thoughts, symmetry, taboo or religious obsessions, hoarding, somatic, relationship-focused, and others. A psychiatrist with broad OCD experience is comfortable across subtypes; one who has primarily seen contamination OCD may have less depth on other presentations.
The area has strong OCD treatment infrastructure, including academic medical centers (Mount Sinai’s OCD program, NYU Langone, Columbia), specialized OCD practices, and individual psychiatrists with deep OCD expertise. Finding the right fit takes some research, but the depth of expertise available in is substantial.
What to expect from an OCD evaluation and treatment plan
An initial OCD evaluation in typically covers several specific elements beyond a general psychiatric evaluation.
Symptom history with attention to OCD subtypes. What specific obsessions and compulsions you experience, when they started, how they have changed over time, and how they fit into the recognized OCD subtypes. Common subtypes include contamination (germs, illness), harm (intrusive violent thoughts), symmetry and ordering, taboo or religious (intrusive sexual or blasphemous thoughts), checking, and somatic (focused on body sensations).
Severity assessment. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is the standard severity measure used in OCD treatment and research. It rates time spent on obsessions and compulsions, distress, interference, resistance, and control across symptom domains. A baseline Y-BOCS score helps track treatment response over time.
Comorbid condition screening. OCD frequently co-occurs with depression, anxiety disorders, ADHD, tic disorders, body dysmorphic disorder, and others. A thorough OCD evaluation screens for these because treatment plans often need to address multiple conditions simultaneously.
Previous treatment history. What OCD medication or other providers have prescribed previously, what doses were reached, how long trials lasted, partial or non-response patterns, any ERP therapy history.
Family history. OCD has meaningful genetic components, and family patterns of OCD, anxiety, tic disorders, or related conditions clarify the clinical picture.
Following the evaluation, the treatment plan typically starts with an SSRI at a low dose with steady titration toward OCD-effective doses over four to eight weeks. Monthly follow-up appointments for the first three to four months allow for dose adjustment based on response and side effects. Referral to an ERP-trained therapist usually happens at the initial evaluation or shortly after, with the goal of starting ERP within the first month or two of medication. Response to OCD treatment patients receive is typically assessed using repeat Y-BOCS scoring at three to six months.
For someone whose OCD has not responded to initial treatment, the next steps include increasing the SSRI dose toward the upper end of the OCD-effective range, switching to a different SSRI, considering clomipramine, or adding antipsychotic augmentation. The sequence depends on individual response patterns and side effect tolerance.
Telehealth vs in-person OCD treatment options
Both telehealth and in-person OCD treatment options have expanded significantly since 2020.
Telehealth OCD medication management works well for ongoing OCD prescribing once the initial evaluation has been completed. Monthly or quarterly follow-up visits for medication adjustment can be done by video without loss of clinical quality for most patients. The convenience makes ongoing care more sustainable, particularly for busy professionals.
Telehealth ERP therapy has been extensively studied and produces outcomes comparable to in-person ERP for most patients. Some exposures (contamination exposures, in particular) can actually be done more naturally at home via video than in a therapist’s office. ERP therapists who work via telehealth in are increasingly available.
In-person care remains preferred or required in some situations. Some practices require an in-person initial evaluation. Patients who would benefit from the structure of leaving home for treatment sometimes prefer in-person sessions. Intensive treatment programs (IOPs and residential) typically require in-person attendance.
My practice offers psychiatric evaluation and OCD medication management via telehealth for patients in New York, including Manhattan and the wider metro, and in-person at my Fort Lee, NJ office for patients in New Jersey. Many patients use the hybrid model: telehealth medication management with me for ongoing symptoms and dose adjustments, in-person or telehealth ERP therapy with a local therapist for the behavioral work alongside the medication management of OCD symptoms.
Cost and insurance for OCD treatment
Cost and insurance coverage for OCD treatment vary significantly by provider type and insurance status.
In-network insurance coverage for OCD medication management typically results in a copay of $20 to $75 per visit. Many academic centers and some private practices accept commercial insurance.
Out-of-network specialty OCD practices are common in . Out-of-network evaluations typically range from $400 to $900 for the initial assessment, with follow-up medication management visits priced lower. Many practices provide superbills for partial reimbursement through out-of-network benefits, typically 60 to 80 percent of the allowed amount after the deductible is met.
ERP therapy insurance coverage varies. Some ERP therapists accept insurance for outpatient mental health visits; others operate on a self-pay or out-of-network model. Sessions typically run weekly during active treatment, then taper to less frequent visits during maintenance.
TMS for OCD is FDA-approved and increasingly covered by commercial insurance with prior authorization. The full course (daily sessions over four to six weeks) involves substantial cost without insurance coverage; with coverage, copays are typically per-session.
Confirming specific costs and coverage with the practice and your insurance before booking is the most reliable way to know what you will pay for OCD treatment services.
When to take the next step
If OCD is regularly disrupting your work, relationships, or daily life, the right next step is an OCD evaluation with a psychiatric provider who has expertise in OCD specifically. Effective OCD treatment patients receive is well established, the medications work for the majority of people who try them at appropriate doses, and ERP therapy alongside medication produces durable results.
I provide comprehensive OCD treatment services including OCD medication management, comprehensive evaluation, and coordination with ERP-trained therapists. Initial consultations are 50 minutes via telehealth for New York patients or in-person at Fort Lee for New Jersey patients. The evaluation covers your OCD subtype, severity, treatment history, comorbid conditions, and what a tailored plan looks like.
For trusted general reference on OCD, the International OCD Foundation (IOCDF) maintains the most comprehensive non-commercial resource on the condition, including diagnostic information, treatment guidance, and a provider finder.
